World Vitamin K2 Market was valued at USD 54.36 million in the year 2018. World Vitamin K2 Market is further estimated to grow at a CAGR of 25.10% from 2019 to 2025, market value in 2019 valued USD 64.54 million reach USD 247.40 million by the year 2025. The North America region holds the highest market share in 2019 and the Asia Pacific is considered as the fastest growing market in the forecasted period. At a country level, US, China are projected to grow strongly in the coming years due to increasing density of population and funding through Research and Development. The World Vitamin K2 Report 2019-2025 covers market opportunities and challenges, key market regulations’ information, analysis of new products from the market players and key market trends, market share analysis for key players, supply chain and value chain analysis, product and technology trends, pricing analysis, emerging applications, technologies and major recent developments. This information has also been provided for the major country markets in these regions. Market shares, size and growth potential are assessed for these major country markets. Market opportunities, challenges, government regulations, market share analysis by major competitors, recent major market developments (product launches, M&A, partnerships, etc.) and other information have been covered for the major country markets listed in this section. On the basis of Type, the market is divided as MK-7, MK-4 and others. In which MK-7 for the largest market share due to increasing demand in future market trends. Regional breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and ROW. Market player analysis of major companies such as Kappa Bioscience, NattoPharma, Gnosis, DSM, Viridis BioPharma, Frutarom, DuPont Nutrition & Health, GeneFerm Biotechnology, Shanghai Reson Biotech, Guangdong Goodscend, Seebio Biotech and Kyowa Hakko.
Scope:
Report Data
Market
Forecast 2022
XX million/billion (2022-2032)
CAGR 2022 - 2032
%
Analysis Period
2022 - 2032
Base Year
2021
Forecast Data
2022 - 2032
Segments Covered
By Type, By Application, And by Regions
Regional Scope
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
1 Introduction 1.1 The objectives of this study 1.2 Market Definition 1.2.1 Market Scope 1.3 Research Methodology 1.4 Stakeholders 1.5 Currency 1.6 Research Assumptions 1.7 Limitation 2 Executive Summary
3. Market Outlook 3.1 Introduction 3.2 Market Drivers 3.3 Market Challenges 3.4 Market Share Analysis 3.5 Value chain Analysis
4 Industry Trends 4.1 Introduction 4.2 PESTEL Analysis 4.3 Porter’s Five Forces Model 4.2.1 Threat of new entrance 4.2.2 Threat of substitute product 4.2.3 Bargaining power of buyer 4.2.4 Bargaining power of supplier 4.2.5 Intensity of competitive rivalry
5 Vitamin K2 Market Type Analysis 5.1 Introduction 5.2 Benchmark Market Revenue Analysis by Type, 2013-2017 5.3 Estimated and Projected Market Analysis by Type, 2018-2025 5.4 Y-o-Y Growth Trend Analysis 5.5 MK-7 5.6 MK-4 5.8 Other
7 World Vitamin K2 Regional Analysis 7.1 Introduction 7.2 North America 7.2.1 Benchmark Market Revenue Analysis by Country, 2013-2017 7.2.2 Estimated and Projected Market Analysis by Country, 2018-2025 7.2.3 U.S. 7.2.4 Canada 7.3 Europe 7.3.1 Benchmark Market Revenue Analysis by Country, 2013-2017 7.3.2 Estimated and Projected Market Analysis by Country, 2018-2025 7.3.3 U.K. 7.3.4 Germany 7.3.5 France 7.3.6 Rest of Europe 7.4 Asia-Pacific (APAC) 7.4.1 Benchmark Market Revenue Analysis by Country, 2013-2017 7.4.2 Estimated and Projected Market Analysis by Country, 2018-2025 7.4.3 Japan 7.4.4 China 7.4.5 India 7.4.6 Rest of APAC 7.5 Rest of the World (RoW) 7.5.1 Benchmark Market Revenue Analysis by Country, 2013-2017 7.5.2 Estimated and Projected Market Analysis by Country, 2018-2025 7.5.3 Middle East 7.5.4 Latin America